Authors:
Weirather JL, Duggal P, Nascimento EL, Monteiro GR, Martins DR, Lacerda HG, Fakiola M, Blackwell JM, Jeronimo SMB, Wilson ME.
Authors notes:
Infection, Genetics and Evolution. 2016;43:1-5.
Keywords:
Fine mapping, Genetic risk factors, Linkage regions, Tropical disease, Visceral leishmaniasis
Abstract:
Infection with the protozoan Leishmania infantum can lead to asymptomatic infection and protective immunity, or to the progressive and potentially fatal disease visceral leishmaniasis (VL).
Published studies show host genetic background determines in part whether infected individuals will develop a symptomatic or asymptomatic outcome.
The purpose of the current study was to fine map chromosome regions previously linked with risk for symptomatic (chromosome 9) or asymptomatic (chromosomes 15 and 19) manifestations of L. infantum infection.
We conducted a family-based genetic study of VL and asymptomatic infection (detected by a DTH skin test) with a final post quality control sample of 961 individuals with full genotype and phenotype information from highly endemic neighborhoods of northeast Brazil.
A total of 5485 SNPs under the linkage peaks on chromosomes 9, 15 and 19 were genotyped.
No strong SNP associations were observed for the DTH phenotype.
The most significant associations with the VL phenotype were with SNP rs1470217 on chromosome 9, and with SNP rs8107014 on chromosome 19. SNP rs1470217 is situated in a 180 kb intergenic region between TMEM215 (Transmembrane protein 215) and APTX (Aprataxin).
SNP rs8107014 lies in the intron between exons 26 and 27 of a 34 exon transcript (ENST00000204005) of LTBP4, (Latent transforming growth factor-beta-binding protein 4a).
The latter supports growing evidence that the transforming growth factor-beta pathway is important in the immunopathogenesis of VL.